Cardiac Changes Associated With Acute Cerebro-vascular Stroke
Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05770050
Collaborator
(none)
145
8
Study Details
Study Description
Brief Summary
Cardiovascular disease is regarded as main predisposing risk factor for cerebrovascular stroke.
Cardiac dysfunction can both worsen the pre existing cerebral damage and cause new brain injury Diseases of the heart and the brain are closely entangled. Vascular diseases of both organs share the same risk factors.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
145 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Cardiac Changes Associated With Acute Cerebrovascular Stroke
Anticipated Study Start Date
:
Apr 1, 2023
Anticipated Primary Completion Date
:
Oct 31, 2023
Anticipated Study Completion Date
:
Dec 1, 2023
Outcome Measures
Primary Outcome Measures
- ECG changes in cerebrovascular accident [6 months]
ECG QT interval, T wave changes in. cerebrovascular accident
- Echo changes in cerebrovascular accident [6 months]
Echo chamber dilatation, valavular, ejection fraction changes in cerebrovascular accident
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
above 18 years
-
patients presented with cerebrovascular stroke 3-patients diagnosed as cardiac patients and have cerebrovascular stroke
Exclusion Criteria:
1-Less than 18 years
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Esraa Mohamed Ali,
Esraa Mohamed Ali,
Assiut University
ClinicalTrials.gov Identifier:
NCT05770050
Other Study ID Numbers:
- CVS and Cardiac changes
First Posted:
Mar 15, 2023
Last Update Posted:
Mar 15, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: